Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 110-116, January 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bouayadi, K.
Right arrow Articles by Cazaux, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bouayadi, K.
Right arrow Articles by Cazaux, C.

Overexpression of DNA Polymerase ß Sensitizes Mammalian Cells to 2',3'-Deoxycytidine and 3'-Azido-3'-deoxythymidine1

Khalil Bouayadi, Jean-Sébastien Hoffmann, Pascal Fons, Michele Tiraby, Jean-Paul Reynes and Christophe Cazaux2

Laboratoire de Microbiologie et de Génétique, Université Paul Sabatier, 118 route de Narbonne, 31062 Toulouse cédex [K. B., P. F., C. C.]; Institut de Pharmacologie et Biologie Structurale, Centre National de la Recherche Scientifique, UPR 9062, 205 route de Narbonne, 31077 Toulouse cédex [J. S. H.]; and Laboratoire CAYLA, Z.I. Montaudran, 5 rue J. Rodier, 31400 Toulouse [M. T., J. P. R.]

Mammalian DNA polymerase ß is a DNA repair enzyme expressed constitutively at a low level. In vitro, purified DNA polymerase (Pol) ß incorporates the nucleotide analogues 2'-3' deoxycytidine (ddC)-triphosphate and 3'-azido-3'-deoxythymidine (AZT)-triphosphate into DNA, causing chain termination. We have tested the possibility of enhancing the cytotoxicity of these chain terminators against mammalian cells by increasing the level of Pol ß. Chinese hamster ovary AA8 and murine melanoma B16 cell lines were stably transfected with rat pol ß cDNA under the control of a viral enhancer/promoter. We found that overexpression of Pol ß sensitized the cells to ddC and AZT. To confirm the role of this polymerase in this process, we prepared cell extracts from the control and Pol ß overexpressing Chinese hamster ovary cell lines and tested in vitro their capacity to incorporate ddC-triphosphate and AZT-triphosphate into DNA. We found that inhibition of DNA replication by both chain terminators was more pronounced when extracts from pol ß-transfected cells were used, providing a direct evidence of the involvement of Pol ß in the sensitization process. In addition, we showed that cotransfection with bacterial or viral thymidine/thymidylate kinase genes enhanced the Pol ß-mediated cytotoxicity of AZT, suggesting that phosphorylation and polymerization activities might be combined to potentiate their respective effects. These observations may be useful for improving therapeutic efficiency of DNA chain terminators.

1 This research was supported by the Région Midi-Pyrénées and the Ligue Nationale Contre le Cancer (axe thérapie génique).

2 To whom requests for reprints should be addressed, at Institut de Pharmacologie et de Biologic Structurale, Centre National de la Recherche Scientifique UPR A9062, 205 route de Narbonne, 31077 Toulouse cédex, France. Fax: 33-5-61-17-59-94; E-mail: cazaux@ipbs.fr.

Received 7/15/96. Accepted 11/ 1/96.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
F. Boudsocq, P. Benaim, Y. Canitrot, M. Knibiehler, F. Ausseil, J. P. Capp, A. Bieth, C. Long, B. David, I. Shevelev, et al.
Modulation of Cellular Response to Cisplatin by a Novel Inhibitor of DNA Polymerase {beta}
Mol. Pharmacol., May 1, 2005; 67(5): 1485 - 1492.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Y. Canitrot, J.-P. Capp, N. Puget, A. Bieth, B. Lopez, J.-S. Hoffmann, and C. Cazaux
DNA polymerase {beta} overexpression stimulates the Rad51-dependent homologous recombination in mammalian cells
Nucleic Acids Res., September 27, 2004; 32(17): 5104 - 5112.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Dalal, J. L. Kosa, and J. B. Sweasy
The D246V Mutant of DNA Polymerase {beta} Misincorporates Nucleotides: EVIDENCE FOR A ROLE FOR THE FLEXIBLE LOOP IN DNA POSITIONING WITHIN THE ACTIVE SITE
J. Biol. Chem., January 2, 2004; 279(1): 577 - 584.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Bergoglio, M.-J. Pillaire, M. Lacroix-Triki, B. Raynaud-Messina, Y. Canitrot, A. Bieth, M. Gares, M. Wright, G. Delsol, L. A. Loeb, et al.
Deregulated DNA Polymerase {beta} Induces Chromosome Instability and Tumorigenesis
Cancer Res., June 1, 2002; 62(12): 3511 - 3514.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Louat, L. Servant, M.-P. Rols, A. Bieth, J. Teissie, J.-S. Hoffmann, and C. Cazaux
Antitumor Activity of 2',3'-Dideoxycytidine Nucleotide Analog Against Tumors Up-Regulating DNA Polymerase beta
Mol. Pharmacol., September 1, 2001; 60(3): 553 - 558.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Y. CANITROT, J.-S. HOFFMANN, P. CALSOU, H. HAYAKAWA, B. SALLES, and C. CAZAUX
Nucleotide excision repair DNA synthesis by excess DNA polymerase {beta}: a potential source of genetic instability in cancer cells
FASEB J, September 1, 2000; 14(12): 1765 - 1774.
[Abstract] [Full Text]


Home page
FASEB J.Home page
Y. CANITROT, M. FRÉCHET, L. SERVANT, C. CAZAUX, and J.-S. HOFFMANN
Overexpression of DNA polymerase ß: a genomic instability enhancer process
FASEB J, June 1, 1999; 13(9): 1107 - 1111.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. L. Kosa and J. B. Sweasy
3'-Azido-3'-deoxythymidine-resistant Mutants of DNA Polymerase beta  Identified by in Vivo Selection
J. Biol. Chem., February 5, 1999; 274(6): 3851 - 3858.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Canitrot, C. Cazaux, M. Frechet, K. Bouayadi, C. Lesca, B. Salles, and J.-S. Hoffmann
Overexpression of DNA polymerase beta  in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs
PNAS, October 13, 1998; 95(21): 12586 - 12590.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.